Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :1914
Small font sizeDefault font sizeIncrease font size
Read this article

 


    Article Cited by others

BREAST - ORIGINAL ARTICLE

Clinical and pathological response rates of docetaxel-based neoadjuvant chemotherapy in locally advanced breast cancer and comparison with anthracycline-based chemotherapies: Eight-year experience from single centre

Gupta D, Raina V, Rath G K, Shukla N K, Mohanti B K, Sharma D N

Year : 2011| Volume: 48| Issue : 4 | Page no: 410-414

   This article has been cited by
 
1 Comparison of efficacy of neoadjuvant chemotherapy FEC 100 and Docetaxel 75 versus AC and Docetaxel in locally advanced breast cancer: a randomized clinical study
K. M. Dhanraj,B. Dubashi,S. Gollapalli,S. Kayal,Sunu Lazar Cyriac
Medical Oncology. 2015; 32(12)
[Pubmed]  [Google Scholar] [DOI]
2 Comparing Role of Two Chemotherapy Regimens, CMF and Anthracycline-Based, on Breast Cancer Survival in the Eastern Mediterranean Region and Asia by Multivariate Mixed Effects Models: a Meta-Analysis
Saeed Ghanbari,Seyyed Mohammad Taghi Ayatollahi,Najaf Zare
Asian Pacific Journal of Cancer Prevention. 2015; 16(14): 5655
[Pubmed]  [Google Scholar] [DOI]
3 Association between Pathological Complete Response and Outcome Following Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients
Sutima Luangdilok,Norasate Samarnthai,Krittiya Korphaisarn
Journal of Breast Cancer. 2014; 17(4): 376
[Pubmed]  [Google Scholar] [DOI]
4 Taxane and Anthracycline Based Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer : Institutional Experience
Ajay Gogia,Vinod Raina,Suryanarayan Vishnu Deo,Nootan Kumar Shukla,Bidhu Kalyan Mohanti,Daya Nand Sharma
Asian Pacific Journal of Cancer Prevention. 2014; 15(5): 1989
[Pubmed]  [Google Scholar] [DOI]

 

  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow